Andrea Farini

Milan, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 48 publications

Withdrawal Note: Microbiota dysbiosis influences immune system and muscle pathophysiology of dystrophin-deficient mice.

Withdrawal Note: Microbiota dysbiosis influences immune system and muscle pathophysiology of dystrophin-deficient mice.

Journal: EMBO molecular medicine

Published: March 16, 2026

Microbiota dysbiosis influences immune system and muscle pathophysiology of dystrophin deficient mice.

Microbiota dysbiosis influences immune system and muscle pathophysiology of dystrophin deficient mice.

Journal: EMBO molecular medicine

Published: March 13, 2026

Dipeptidyl peptidase 3 sets the threshold for immune activation and survival during experimental bacterial infection.

Dipeptidyl peptidase 3 sets the threshold for immune activation and survival during experimental bacterial infection.

Journal: Nature communications

Published: July 25, 2025

Inhibition of HuR/ELAVL-1 attenuates fibrotic progression in Mdx mice with dilated cardiomyopathy.

Inhibition of HuR/ELAVL-1 attenuates fibrotic progression in Mdx mice with dilated cardiomyopathy.

Journal: Cellular and molecular life sciences : CMLS

Published: May 06, 2025

Porphyromonas gingivalis fuels colorectal cancer through CHI3L1-mediated iNKT cell-driven immune evasion.

Porphyromonas gingivalis fuels colorectal cancer through CHI3L1-mediated iNKT cell-driven immune evasion.

Journal: Gut microbes

Published: August 12, 2024

Editorial: Inflammation in muscular dystrophies: mediators, mechanisms, and therapeutics.

Editorial: Inflammation in muscular dystrophies: mediators, mechanisms, and therapeutics.

Journal: Frontiers in immunology

Published: July 25, 2024

Exploring the Gut Microbiota-Muscle Axis in Duchenne Muscular Dystrophy.

Exploring the Gut Microbiota-Muscle Axis in Duchenne Muscular Dystrophy.

Journal: International journal of molecular sciences

Published: April 17, 2024

Advancing Biomarker Discovery and Therapeutic Targets in Duchenne Muscular Dystrophy: A Comprehensive Review.

Advancing Biomarker Discovery and Therapeutic Targets in Duchenne Muscular Dystrophy: A Comprehensive Review.

Journal: International journal of molecular sciences

Published: November 23, 2023

Immunoproteasome Inhibition Positively Impacts the Gut-Muscle Axis in Duchenne Muscular Dystrophy.

Immunoproteasome Inhibition Positively Impacts the Gut-Muscle Axis in Duchenne Muscular Dystrophy.

Journal: Journal of cachexia, sarcopenia and muscle

Published: November 02, 2023

Correction: IPSC derived cardiac fibroblasts of DMD patients show compromised actin microfilaments, metabolic shift and pro-fibrotic phenotype.

Correction: IPSC derived cardiac fibroblasts of DMD patients show compromised actin microfilaments, metabolic shift and pro-fibrotic phenotype.

Journal: Biology direct

Published: October 07, 2023

Magnetic-field-driven targeting of exosomes modulates immune and metabolic changes in dystrophic muscle.

Magnetic-field-driven targeting of exosomes modulates immune and metabolic changes in dystrophic muscle.

Journal: Nature nanotechnology

Published: July 14, 2023

Flvcr1a deficiency promotes heme-based energy metabolism dysfunction in skeletal muscle.

Flvcr1a deficiency promotes heme-based energy metabolism dysfunction in skeletal muscle.

Journal: Cell reports

Published: June 30, 2023

Showing 1-12 of 48

Last Updated: 09/26/2026